Purpose: To report a patient with a tumor-like corneal keloid.
C orneal keloid, first described in 1865, 1 is a rare condition consisting of a proliferation of benign fibrovascular tissue. There have been approximately 76 documented cases of corneal keloid previously reported. Most reported cases have occurred secondary to penetrating injury or surgery, and it is thought that inflammation causes a fibroblastic reaction resulting in the keloid. 24, 27 Herein, we report a case of corneal keloid that developed in a patient with no history of ocular surgery or trauma. There have been other instances where corneal keloid formed in patients without prior corneal injury. Our patient had a remote history of radiation therapy for an orbital tumor and a tarsorrhaphy, which may have contributed to the keloid formation.
CASE REPORT
A 68-year-old African American woman was evaluated in July 2007 for an enlarging growth and bloody discharge from her right eye. The lesion had been present for 2 years and had progressively enlarged. She had no history of trauma or ocular surgery. In 1991, she related that she had been treated with radiation therapy for an orbital tumor and a tarsorrhaphy, although further details about that treatment were unavailable. A previous biopsy of the orbital mass showed fibroinflammatory tissue. She had no history of inflammatory eye disease, and her medical history was otherwise unremarkable.
On initial presentation, she had no light perception vision in her right eye and the best-corrected vision in her left eye was 20/25. Abnormal findings were confined to her right eye. External examination showed a smooth, white-to-tan, raised corneal mass covering the entire corneal surface (Fig. 1) . She also had evidence of a tarsorrhaphy. Applanation tonometry, anterior segment examination, and dilated fundus examination were precluded by the corneal mass. Magnetic resonance imaging of the right orbit showed a 3 3 1 cm soft tissue mass around the optic nerve in the central and lateral superior aspect of the orbit. A biopsy of the corneal lesion showed nonspecific fibrocellular tissue. The patient underwent enucleation of her blind painful right eye. Gross examination of the enucleated eye showed a 9 3 8 3 3 mm corneal mass (Fig. 2) . The lens was opaque, and the vitreous was collapsed. The retina was atrophic. Microscopic examination showed that the corneal mass was located between the epithelium and the Bowman layer (Fig. 3) . The mass was composed of bland spindle-shaped cells enmeshed in a loosely cohesive collagenous matrix with interspersed vascular channels. Portions of the mass were heavily collagenized, vascularized, and contained pigmented and nonpigmented cells, whereas other portions were more loosely cohesive (Fig. 4) . Bowman layer was disrupted underlying the mass. The corneal stroma was edematous and scarred. There was neovascularization of the iris, peripheral anterior synechiae, cataractous changes in the lens, and glaucomatous atrophy of the retina and optic nerve. A trichrome stain highlighted the collagen bundles in the corneal mass, and immunohistochemical stains were positive for smooth muscle actin cells in the mass (Fig. 5) . The corneal mass was classified as a keloid. The postoperative course was uneventful.
DISCUSSION
Corneal keloid may present at any age, although they most commonly present in the first 2 decades of life. 19, 23 The clinical differential diagnosis includes sclerocornea, dermoid, myxoma, Salzmann nodular degeneration, Peter anomaly, congenital hereditary endothelial dystrophy, congenital glaucoma, familial band-shaped keratopathy, spheroidal degeneration, squamous cell carcinoma, juvenile xanthogranuloma, fibrous histiocytoma, birth trauma, infection, and metabolic disease. 8, 10, 13, 15, 19 Persons of African or Asian heritage are more susceptible than whites for developing cutaneous keloid, 7 although it is unknown if this holds true for corneal keloid. However, Lahav et al 7 reported 9 cases of corneal keloid in 45 eyes of young African patients and noted that the keloids often occurred after untreated penetrating corneal injury.
Corneal keloid clinically appears as a solitary, graywhite, firm, elevated, smooth, shiny nodule that is well demarcated from the adjacent tissue, although it may involve the entire corneal stroma. 10, 17, 24 There is often a clinical history of penetrating or nonpenetrating injury preceding the development of the keloid. Corneal thickening is caused by fibrovascular hyperplasia secondary to scar formation. The lesion often covers a large area of the corneal surface, well beyond the presumed localized site of injury. 2, 11, 17, 24, 26 Ultrasound evaluation of corneal keloid usually shows a solid lesion with high echogenicity, 13 a thickened cornea, poorly defined angle anatomy, and possible iridocorneal touch. 10 Anterior chamber and lens structures are usually normal unless there is an associated heritable syndrome. 11 If the keloid arises secondary to penetrating trauma, iris incarceration into the wound may also be present. 19 The diagnosis of most cases of corneal keloid has been made by pathologic examination rather than clinical examination. 11, 17 The thickened epithelium may exhibit hyperplasia, keratinization, parakeratosis, and basilar edema. Bowman layer is usually disrupted or absent. 26 The stroma may contain irregularly arranged fibroblasts, collagen bundles, and vascular channels 7, 10, 15, 16, 19, 23 along with activated fibroblasts, myofibroblasts, and hyalinized collagen in later stages. 7, 24, 26 Neovascularization may be located anteriorly or diffusely throughout the stroma with the origin of the vessels from either the peripheral cornea or the incarcerated iris. 17, 24 The keloid from our patient had many of these findings, including hyperplastic epithelium overlying edematous heavily collagenized fibrovascular tissue. The underlying Bowman layer was disrupted, and activated fibroblasts along with vascular channels were present within the keloid.
The histogenesis of keloid may be divided into an early inflammatory stage followed by fibroblastic, fibrous, and hyaline stages. Initially, there is increased vascularity, hyperplasia of juvenile fibroblasts, and production of collagen type III fibrils during the inflammatory and fibroblastic stages. During the fibrous stage, collagen type I becomes tightly packed and there is a reduction in both vascularity and juvenile fibroblasts. Compact collagen stroma then fuses and becomes homogenous to form the final hyaline stage. 7, 24, 26 It is believed that in keloids, myofibroblasts, which are transformed fibroblasts, that express smooth muscle phenotypes persist and often dominate the cell population. Eventually, they deposit material that slowly collagenizes in the center but does not retract. This produces a bulky slow growth of active fibroblasts and myofibroblasts. 7,11,17,19.20 We determined that the keloid in our patient was in the late fibroblastic or fibrous stage in our patient from the histopathologic findings of diffuse fibrovascular tissue, vascular channels, heavy collagenization, and limited amounts of hyaline tissue.
Based on cases of perforating injury, some have suggested that corneal keloids originate from stromal cells of the iris incarcerated into the corneal site, thus inducing proliferation. In those instances, blood vessels within the keloid originate from iris tissue. 5, 18 Others have suggested that excessive proliferation of fibrovascular connective tissue occurs during the healing phase of an inflammatory reaction or perforating injury and does not necessarily result from the iris incarceration. 18, 19 Although iris incarceration is a possible explanation, there are corneal keloids that form after penetrating trauma where no iris cells are present within the proliferating fibrovascular tissue. 3 O#Grady and Kirk 3 reviewed 4 cases and found that keloid formation was from relatively normal peripheral cornea and only one traumatic case had iris pigment present in the keloid. There have also been 2 cases of nonpenetrating injury where a corneal keloid developed without evidence of perforation or iris involvement. 17, 24 Based on the report by O#Grady and Kirk and these other cases, it is likely that corneal stromal overgrowth during the reparative phase of corneal healing in response to an inflammatory process or injury may lead to keloid development. 6, 7, 16, 23 Our patient had a history of radiation and a tarsorrhaphy for exposure keratopathy, and the exposure keratopathy was the likely cause of the keloid formation.
Corneal keloids are also common with certain genetic syndromes. Lowe syndrome, an X-linked recessive disorder characterized by hydrophthalmia, cataracts, intellectual disabilities, aminoaciduria, and vitamin D resistance rickets, has been associated with congenital corneal keloids. 14, 18, 22, 28 It is believed that in Lowe syndrome, increased levels of amino acids such as tyrosine leaking from abnormal new corneal vessels, or from within the anterior chamber through defective endothelium, stimulate fibroblast proliferation. 14, 20, 22 Another genetic syndrome associated with corneal keloids is Rubinstein-Taybi syndrome. Rao et al 10 reported bilateral corneal keloids along with the Rubinstein-Taybi syndrome constellation of symptoms of broad thumbs and great toes, short stature, mental retardation, congenital heart defects, and characteristic faces. Besides these 2 genetic syndromes, authors have reported that congenital corneal keloids are associated with ocular anomalies such as peripheral iridocorneal adhesions, subluxated lenses, 21 aniridia, and cataract with anophthalmia. 15 In those idiopathic cases, it is postulated that there was a failure of normal corneal tissue differentiation during embryogenesis, resulting in the occurrence of keloids and concomitant failure of the development of normal ocular tissue. 15, 20, 21 Congenital and genetic syndrome keloids seem to be a result of anterior segment mesenchymal dysgenesis.
There have been 3 cases of corneal keloids in patients who did not have congenital corneal keloids, had no prior history of ocular injury or trauma, had no prior history of chronic inflammation, and had no family history of fibrovascular proliferative disease. Holbach et al 8 reported 2 cases of bilateral corneal keloids in two 6-month-old boys and hypothesized that unrecognized corneal infection could introduce microbial antigens, which created an immune-mediated reaction resulting in a hypertrophic keloid. Mejia et al 26 reported on a 17-year-old case and proposed that fibrovascular overgrowth was because of effects of cytokines released by injured epithelium affecting the normal corneal response to injury. This explanation was supported by Dhooge et al 2 who reported that a child with fibrodysplasia ossificans progressiva had developed a unilateral keloid after pterygium repair. They hypothesized that high levels of bone morphogenic protein 4 (BMP4) in fibrodysplasia ossificans progressiva inhibited the normal signaling of transforming growth factor b and activin, therefore overstimulating fibroblastic growth in corneal wound healing. Cytokines such as basic fibroblast growth factor can have an inhibitory effect on the function of transforming growth factor b, a paracrine and autocrine hormone, involved with the normal differentiation of corneal stroma and wound contraction. 26, 27 Basic fibroblast growth factor has been shown to induce profound keratocyte proliferation and wound neovascularization. 27 Shoukrey and Tabbara   24 showed that basal epithelial cells can transform into myofibroblasts and develop contractile elements and cytokines may promote unregulated fibrovascular growth into a corneal keloid. In our case, there was apparent radiation damage to intraocular structures such as the iris, lens, and retina. On histopathologic examination, the iris leaflets exhibited neovascularization. The iris was also adherent to the posterior surface of the cornea. Within the posterior corneal stroma, there was diffuse vascularization most likely from the longstanding corneal disease. We believe that the chronic inflammation from the iris tissue, and possibly leakage of amino acids from the neovascularization within the posterior stroma, could have created the persistent inflammatory state that triggered fibrovascular growth. Inflammatory cytokines such as basic fibroblastic growth factor and interferons could have been released from the blood vessels and injured epithelial cells, creating the ongoing proliferation of fibrous tissue and vascular channels.
Successful treatment of corneal keloid has included superficial keratectomy, lamellar excision, lamellar keratoplasty, or penetrating keratoplasty. Lamellar keratectomy is possible unless there is deep stromal involvement of the lesion. 18 Several authors have reported success with superficial lamellar keratectomy with amniotic membrane coverage. 11, 13 Sclerokeratoplasty has also been performed successfully as an alternative procedure to preserve the globe when conventional keratoplasty could not be performed secondary to severe destruction of the cornea. Visual results from all the procedures are variable, but anterior reconstruction of the eye is usually good. 16 Although benign growths, keloids may severely affect vision resulting in cases of no light perception, and large hypertrophic scars may interfere with eyelid closure. 18 These lesions may also become irritated from exposure and become extremely painful. Incomplete surgical excision of keloids can result in recurrence and enlargement of the lesions. 18, 24 Recurrence has been reported after superficial lamellar keratectomy 8, 24, 25 and penetrating keratoplasty. 10 In cases of congenital corneal keloid, penetrating keratoplasty is difficult and commonly complicated by corneal graft failure secondary to recurrent epithelial breakdown. 10, 15 Enucleation is rarely performed unless the eye is nonfunctional, painful, and aesthetically displeasing. 3, 7 Treatment goals are directed at removing the existing lesion and preventing recurrence by inhibiting fibroblastic proliferation and collagen synthesis. In the ultrastructural analysis of corneal keloids, it was noted that the persistence of mast cells promotes recurrent inflammation and utilizing topical steroids or mast cell stabilizers may be useful. 14, 18 Other options that have been proposed include topical cyclosporine 22 or the use of physical forms of treatment such as ultrasound, cryotherapy, pressure therapy, and laser. 18 The utilization of amniotic membrane after superficial keratectomy has been successful in preventing recurrence and epithelial breakdown because of its antifibroblastic and anti-inflammatory properties. 13 
